These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22422834)

  • 21. Validity of subgroup comparisons in real-life studies.
    Mole T
    J Wound Care; 2006 Nov; 15(10):461; author reply 461-2. PubMed ID: 17124821
    [No Abstract]   [Full Text] [Related]  

  • 22. Statistical principles: myths or facts?
    Sylvester R
    Onkologie; 2003 Dec; 26(6):520-1. PubMed ID: 14709923
    [No Abstract]   [Full Text] [Related]  

  • 23. Statistical trial designs and clinical practice: are they compatible?
    Punt CJ
    Onkologie; 2003 Dec; 26(6):518-9. PubMed ID: 14709922
    [No Abstract]   [Full Text] [Related]  

  • 24. Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods.
    Graves N; Walker D; Raine R; Hutchings A; Roberts JA
    Health Econ; 2002 Dec; 11(8):735-9. PubMed ID: 12457373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-hoc data analysis: benefits and limitations.
    Curran-Everett D; Milgrom H
    Curr Opin Allergy Clin Immunol; 2013 Jun; 13(3):223-4. PubMed ID: 23571411
    [No Abstract]   [Full Text] [Related]  

  • 26. Early viewing of noninferiority trials in progress.
    Dignam JJ
    J Clin Oncol; 2005 Aug; 23(24):5461-3. PubMed ID: 16027438
    [No Abstract]   [Full Text] [Related]  

  • 27. [Randomized study of n-of-1 trials versus standard practice].
    Chatellier G
    Rev Epidemiol Sante Publique; 1996 Aug; 44(4):382-3. PubMed ID: 8927783
    [No Abstract]   [Full Text] [Related]  

  • 28. Subgroup analyses: how to avoid being misled.
    Fletcher J
    BMJ; 2007 Jul; 335(7610):96-7. PubMed ID: 17626964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subgroup analyses: primary and secondary.
    Detsky AS; Naglie IG
    ACP J Club; 1995; 122(3):A12-4. PubMed ID: 7728420
    [No Abstract]   [Full Text] [Related]  

  • 30. Annals of Emergency Medicine Journal Club. Outcome measures, interim analyses, and Bayesian approaches to randomized trials: answers to the September 2009 Journal Club questions.
    Brown AM; Schriger DL; Barrett TW
    Ann Emerg Med; 2010 Feb; 55(2):216-224.e1. PubMed ID: 20116032
    [No Abstract]   [Full Text] [Related]  

  • 31. Sample size determination and statistical power in randomized controlled trials.
    Sjögren P; Hedström L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):652-3. PubMed ID: 20416528
    [No Abstract]   [Full Text] [Related]  

  • 32. Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations.
    Hannan EL
    JACC Cardiovasc Interv; 2008 Jun; 1(3):211-7. PubMed ID: 19463302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re: Statin treatment withdrawal in ischemic stroke: a controlled randomized study.
    Mascitelli L; Pezzetta F
    Neurology; 2008 May; 70(19):1720-1; author reply 1721. PubMed ID: 18458235
    [No Abstract]   [Full Text] [Related]  

  • 34. Is Propensity Score Analysis a Valid Surrogate of Randomization for the Avoidance of Allocation Bias?
    Torres F; Ríos J; Saez-Peñataro J; Pontes C
    Semin Liver Dis; 2017 Aug; 37(3):275-286. PubMed ID: 28847037
    [No Abstract]   [Full Text] [Related]  

  • 35. Re: The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials.
    Shrier I
    Stat Med; 2008 Jun; 27(14):2740-1; author reply 2741-2. PubMed ID: 18069729
    [No Abstract]   [Full Text] [Related]  

  • 36. Electronic monitoring: who needs a trojan horse?
    Vintzileos AM
    Birth; 1994 Dec; 21(4):235-6. PubMed ID: 7857472
    [No Abstract]   [Full Text] [Related]  

  • 37. Primer: the fallacy of subgroup analysis.
    Guillemin F
    Nat Clin Pract Rheumatol; 2007 Jul; 3(7):407-13. PubMed ID: 17599075
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On stratification, minimization and protection against types 1 and 2 error.
    Bracken MB
    J Clin Epidemiol; 2001 Jan; 54(1):104-5. PubMed ID: 11246516
    [No Abstract]   [Full Text] [Related]  

  • 39. No improvement in the reporting of clinical trial subgroup effects in high-impact general medical journals.
    Gabler NB; Duan N; Raneses E; Suttner L; Ciarametaro M; Cooney E; Dubois RW; Halpern SD; Kravitz RL
    Trials; 2016 Jul; 17(1):320. PubMed ID: 27423688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statistical management of data in clinical research.
    Fleiss JL; Kingman A
    Crit Rev Oral Biol Med; 1990; 1(1):55-66. PubMed ID: 2101261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.